Our commitment to addressing health disparities and diversity

We will accelerate our work with key advocates to reach at-risk patients with disease awareness and education. We will also increase awareness of our patient support programs to ensure at-risk communities can access them, including the BMS Patient Assistance Foundation. We will continue to advocate for policies that promote health equity and address racial disparities.

While most efforts to increase diversity in clinical trials focus on community outreach and engagement, we will increase diversity by addressing who the investigators are and where clinical trials are run. We will work to extend the reach of clinical trials into underserved patient communities in urban and rural U.S. geographies by building infrastructure and training and mentoring 250 racially and ethnically diverse clinical investigators. 

We will spend $1 billion globally by 2025 with Black/African American and other diverse-owned businesses to help create jobs and generate positive economic impact in diverse communities often hard hit financially by systemic injustices.

Starting September 1, we will provide a 2-to-1 match for U.S. and Puerto Rico employee donations to organizations that fight disparities and discrimination. We will work with our People & Business Resource Groups (PBRGs) and the BMS Foundation to identify those organizations. 

We have taken significant steps inside our organization toward transforming our culture — efforts that have already made measurable change across our workforce, including reaching gender parity in 2015. Building on our existing focus, by 2022 we aim to: achieve gender parity at the executive level globally; double executive representation of Black/African American employees in the U.S.; and, double executive representation of Hispanic/Latino employees in the U.S.